![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 4, 2380-2389, January 27, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







1
From the
Max Planck Institute of Molecular Genetics, D-14195 Berlin-Dahlem,
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, D-24105 Kiel, and ¶Conaris Research Institute AG, D-24105 Kiel, Germany
NOD2, a cytosolic receptor for the bacterial proteoglycan fragment muramyl dipeptide (MDP), plays an important role in the recognition of intracellular pathogens. Variants in the bacterial sensor domain of NOD2 are genetically associated with an increased risk for the development of Crohn disease, a human chronic inflammatory bowel disease. In the present study, global protein expression changes after MDP stimulation were analyzed by two-dimensional PAGE of total protein extracts of human cultured cells stably transfected with expression constructs encoding for wild type NOD2 (NOD2WT) or the disease-associated NOD2 L1007fsinsC (NOD2SNP13) variant. Differentially regulated proteins were identified by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) peptide mass fingerprinting and MALDI MS/MS. The limited overlap in the responses of the NOD2-overexpressing cell lines to MDP included a down-regulation of heat shock 70-kDa protein 4. A complex pro-inflammatory program regulated by NOD2WT that encompasses a regulation of key genes involved in protein folding, DNA repair, cellular redox homeostasis, and metabolism was observed both under normal growth conditions and after stimulation with MDP. By using the comparison of NOD2WT and disease-associated NOD2SNP13 variant, we have identified a proteomic signature pattern that may further our understanding of the influence of genetic variations in the NOD2 gene in the pathophysiology of chronic inflammatory bowel disease.
Received for publication, June 1, 2005 , and in revised form, October 18, 2005.
* This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 415, by the Proteomverbund Competence Network within the National Genome Research Network, the German Ministry for Education and Research, and the European Commission (EU FP5 Genomics of IBD). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains Figs. S1S4 and Table 1.
1 To whom correspondence should be addressed: Institute of Clinical Molecular Biology of the University Hospital Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 12, D-24105 Kiel, Germany. Tel.: 49-431-597-1373; Fax: 49-431-597-1842; E-mail: s.schreiber{at}mucosa.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Till, P. Rosenstiel, K. Brautigam, C. Sina, G. Jacobs, H.-H. Oberg, D. Seegert, T. Chakraborty, and S. Schreiber A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion J. Cell Sci., February 15, 2008; 121(4): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fillon, K. Soulis, S. Rajasekaran, H. Benedict-Hamilton, J. N. Radin, C. J. Orihuela, K. C. El Kasmi, G. Murti, D. Kaushal, M. W. Gaber, et al. Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology J. Immunol., November 1, 2006; 177(9): 6182 - 6191. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |